Name | Timosaponin A-III |
---|---|
Synonyms |
Timosaponin A3
XilingsaponinA (3β,5β)-Spirostan-3-yl 2-O-β-D-glucopyranosyl-β-D-galactopyranoside Filiferin B β-D-Galactopyranoside, (3β,5β)-spirostan-3-yl 2-O-β-D-glucopyranosyl- Timosaponina- |
Description | Timosaponin AIII could inhibit acetylcholinesterase (AChE) activity, with an IC50 of 35.4 μM. |
---|---|
Related Catalog | |
Target |
IC50: 35.4 μM (AChE)[1]. |
In Vitro | Timosaponin AIII could inhibit acetylcholinesterase (AChE) activity, with an IC50 of 35.4 μM[1]. Timosaponin AIII is identified as a major selective cytotoxic activity in BN108, and its selective cytotoxic activity involves inhibition of mTOR, induction of ER stress and protective autophagy[2]. |
In Vivo | Of the tested steroidal saponins, Timosaponin AIII (TA3) most potently improves memory deficits. Timosaponin AIII increases the scopolamine-induced reduction in step-through latency by 17% (10 mg/kg), 28% (20 mg/kg), and 43% (40 mg/kg). During the acquisition trial, no differences in latent time are observed. Timosaponin AIII (20, 40 mg/kg, p.o.) potently inhibits this reduction of acetylcholine in scopolamine-treated mouse brain. The inhibitory effect of Timosaponin AIII is comparable to that of tacrine, which is used as a positive control[1]. |
Animal Admin | Mice[1] Male ICR mice weighing 28-30 g are used. For the acquisition trial, mice are initially placed in the illuminated compartment and the door between the two compartments is opened 10 s later. Each group contains ten mice. One hour or 5 h before the acquisition trial, mice receive each test agent (e.g., Timosaponin AIII 10, 20 or 40 mg/kg, p.o. ). One hour before the acquisition trial, mice receive tacrine (10 mg/kg, p.o.) as a positive control. Memory impairment is induced by scopolamine treatment (1 mg/kg, i.p.) 0.5 h or 4.5 h after the administration of test agents, tacrine, or 10% Tween 80 solution. Control animals are administered 10% Tween 80 solution alone. Twenty-four hours after the acquisition trial, the mice are again placed in the illuminated compartment for retention trials. The time taken for a mouse to enter the dark compartment after the door opened is measured as the latency time in both acquisition and retention trials, with a maximum of 300 s[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 862.8±65.0 °C at 760 mmHg |
Molecular Formula | C39H64O13 |
Molecular Weight | 740.918 |
Flash Point | 475.6±34.3 °C |
Exact Mass | 740.434692 |
PSA | 196.99000 |
LogP | 3.94 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.606 |
Hazard Codes | Xn |
---|
~% 41059-79-4 |
Literature: Kintya, P. K.; Shvets, S. A. Chemistry of Natural Compounds, 1984 , vol. 20, p. 575 - 578 Khimiya Prirodnykh Soedinenii, 1984 , # 5 p. 610 - 614 |
Precursor 1 | |
---|---|
DownStream 0 |